Online Only Articles

Calreticulin as a novel B-cell receptor antigen in chronic lymphocytic leukemia

Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy;Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
Pepscan, Lelystad, the Netherlands
Pepscan, Lelystad, the Netherlands
IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy
IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Vol. 102 No. 10 (2017): October, 2017 https://doi.org/10.3324/haematol.2017.169102